Log in

Relevant bibliographies by topics / Epstein-Barr virus. Epstein-Barr virus

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Epstein-Barr virus. Epstein-Barr virus'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Epstein-Barr virus. Epstein-Barr virus.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Epstein-Barr virus. Epstein-Barr virus"

1

Rickinson, Alan. "Epstein–Barr virus." Virus Research 82, no. 1-2 (December 2001): 109–13. http://dx.doi.org/10.1016/s0168-1702(01)00436-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Crawford, Dorothy H. "Epstein–Barr Virus." Lancet Infectious Diseases 6, no. 3 (March 2006): 138. http://dx.doi.org/10.1016/s1473-3099(06)70408-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Nicolas, Jean-Claude. "Virus Epstein-Barr." EMC - Biologie Médicale 1, no. 1 (January 2006): 1–8. http://dx.doi.org/10.1016/s2211-9698(06)76372-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Rugge, Massimo, and Robert M. Genta. "Epstein-Barr Virus." Journal of Clinical Gastroenterology 29, no. 1 (July 1999): 3–5. http://dx.doi.org/10.1097/00004836-199907000-00002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Schooley, R. T. "Epstein—Barr virus." Current Opinion in Infectious Diseases 2, no. 2 (April 1989): 267–71. http://dx.doi.org/10.1097/00001432-198904000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Sangüeza, Omar P. "Epstein-Barr Virus." Archives of Dermatology 133, no. 9 (September 1, 1997): 1156. http://dx.doi.org/10.1001/archderm.1997.03890450106013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Junker, A. K. "Epstein-Barr Virus." Pediatrics in Review 26, no. 3 (March 1, 2005): 79–85. http://dx.doi.org/10.1542/pir.26-3-79.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jenson, H. B. "Epstein-Barr Virus." Pediatrics in Review 32, no. 9 (September 1, 2011): 375–84. http://dx.doi.org/10.1542/pir.32-9-375.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gequelin, Luciana Cristina Fagundes, Irina N. Riediger, Sueli M. Nakatani, Alexander W. Biondo, and Carmem M. Bonfim. "Epstein-Barr virus." Revista Brasileira de Hematologia e Hemoterapia 33, no. 5 (2011): 383–88. http://dx.doi.org/10.5581/1516-8484.20110103.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Alfieri, Caroline. "Epstein‐Barr Virus:Epstein‐Barr Virus." Clinical Infectious Diseases 43, no. 5 (September 2006): 669–70. http://dx.doi.org/10.1086/506445.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Epstein-Barr virus. Epstein-Barr virus"

1

Kalla, Markus. "Epigenetik von Epstein-Barr Virus." Diss., lmu, 2008. http://nbn-resolving.de/urn:nbn:de:bvb:19-90227.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pattle, Samuel Benjamin. "Epstein-Barr virus EBER RNAs." Thesis, Imperial College London, 2006. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.430939.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Al-Mozaini, Maha Ahmed. "Epstein-Barr virus BART gene products." Thesis, Imperial College London, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.479170.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Bosshard, Rachel. "Epstein-Barr virus encoded EBER RNAs." Thesis, Imperial College London, 2012. http://hdl.handle.net/10044/1/9698.

Full text

Abstract:

Epstein-Barr virus (EBV) establishes a lifelong latent infection in 95% of the world’s population and is associated with several human cancers. Some of the most abundant viral products in latent infection are the functional EBV-encoded RNAs EBER1 and EBER2. The aim of this thesis was the identification of distinct functions of EBER1 and EBER2 during EBV infection. Epstein-Barr virus bacterial artificial chromosomes with deletion of either EBER1 or EBER2 and corresponding revertant viral genomes were constructed to analyse broad range effects of EBER1 or EBER2 on host cell gene expression. The resulting recombinant viruses were used to infect primary B lymphocytes and establish lymphoblastoid cell lines (LCLs). Microarray expression profiling revealed clear changes in host cell gene expression correlating with EBER expression and significant differences between gene sets regulated with EBER1 and EBER2. Functions of EBER target genes include membrane signalling, regulation of apoptosis and the interferon response. In additional studies, the interaction of EBER1 with ribosomal protein L22 (RPL22), a component of the large ribosomal subunit, was demonstrated in LCL extracts. Using recombinant viruses and EBER expression vectors, the nuclear redistribution of RPL22 by EBER1 was investigated. The delocalisation of RPL22 from nucleoli into the nucleoplasm upon EBV infection was demonstrated in HEK 293, nasopharyngeal carcinoma and gastric carcinoma-derived cell lines. EBER1 was identified as the only viral component necessary for the delocalisation of RPL22. In contrast to the cancer-derived cell lines, LCLs showed a predominantly cytoplasmic expression of RPL22, which was not significantly changed by EBER1. Subsequently, a possible role of RPL22 and EBER1 in p53-dependent stress responses was explored. The data presented in this thesis provide further understanding of the role of EBERs in EBV infection and several of the EBER-regulated genes might be used as markers to elucidate the mechanism of EBER action.

APA, Harvard, Vancouver, ISO, and other styles

5

McDonald, Carol Marie. "Regulation of Epstein-Barr virus BZLF1." Thesis, Imperial College London, 2009. http://hdl.handle.net/10044/1/4430.

Full text

Abstract:

Epstein-Barr virus (EBV) establishes a latent infection in the human host. In order to produce infectious virus particles EBV must reactivate from latency and enter its lytic cycle. BZLF1 is the immediate early gene in EBV that mediates the switch between latency and the lytic cycle. The BZLF1 gene is under the control of the Zp promoter. Reactivation from latency is studied in EBV positive Akata cell lines where EBV can be reactivated by crosslinking the B-cell receptor (BCR) using antibodies to mimic antigen binding. This system uses stably transfected reporter plasmids to study Zp regulation. Mutagenesis identified additional regions of the promoter that contribute to regulation and the ZID MEF2 binding site was demonstrated to be functionally important during the initial stages of Zp activation. XBP-1 splicing, previously implicated in Zp reactivation, was found to occur rapidly in this system in response to BCR crosslinking and parallels the transient induction of Zp. Chromatin remodelling also plays an important role in Zp regulation. An inducible BZLF1 expression system, independent of BCR signalling, was developed in Akata cells that accurately mimics BZLF1 activity and provides a novel approach to study repression at Zp. The BZLF1 protein is related to the bZIP family of transcription factors. BZLF1 contains a bZIP motif in which C-terminal residues fold back against a zipper region that forms an a-helical coiled-coil. The 208SSENDRLR215 sequence in the zipper region is conserved between BZLF1 and C/EBP. Point mutagenesis in this sequence revealed the importance of individual residues for transactivation and progression to DNA replication. The restoration of BZLF1 DNA replication activity by complementation of two deleterious mutations (S208E and D236K) indicated that the interaction of the C-terminal tail and the core zipper region is required for DNA replication, identifying a functional role for this structural feature unique to BZLF1.

APA, Harvard, Vancouver, ISO, and other styles

6

Cameron, Barbara Medical Sciences Faculty of Medicine UNSW. "Immunological and virological correlates of persistent illness following primary Epstein-Barr virus infection." Awarded by:University of New South Wales. School of Medical Sciences, 2005. http://handle.unsw.edu.au/1959.4/22373.

Full text

Abstract:

Primary Epstein-Barr virus (EBV) infection in childhood is typically asymptomatic, but infection later in life results in a mononucleosis with the illness severity ranging from asymptomatic to requiring hospitalisation. The illness is generally short-lived (four to six weeks following onset of symptoms), but persistent disabling symptoms (lasting up to 6 months or longer) are well described in around ten percent of individuals. The aim of this work was to characterise immunological and virological parameters in the peripheral blood, which correlate with persistence of symptoms following EBV-induced mononucleosis. Subjects were recruited prospectively following confirmed primary EBV infection, to allow blood samples and clinical data to be collected at multiple timepoints (baseline, 2 weeks, 4 weeks, 3 months and at least 12 months later). Subjects with 6 months or more of disabling symptoms were defined as ???cases??? with control subjects being those whose illness resolved within 6 weeks of enrolment. Cases were compared with control subjects in terms of: cellular EBV viral load in the peripheral blood by PCR; development of antibodies against EBV VCA (IgG and IgM) and EBNA-1 (IgG) by ELISA; proportions of peripheral blood leucocyte subsets and their activation status by flow cytometry; the magnitude, kinetics of development, and breadth of the CD8+ cytotoxic cell response by interferon-?? Elispot; cytokine levels in serum, and production by peripheral blood mononuclear cells ex vivo; and gene expression patterns in peripheral blood mononuclear cells by microarray. With the exception of gene expression, none of these parameters correlated with early resolution of symptoms or predicted clinical outcome following primary EBV infection. Antibody patterns suggest a tendency to Th2 type immune response may be associated with persistent illness. Preliminary analysis of the gene expression studies indicates that there are many genes involved in this complex disease requiring further investigation. Persistent illness following EBV infection is not associated with uncontrolled viral replication, or chronic immune activation due to an aberrant primary immune response.

APA, Harvard, Vancouver, ISO, and other styles

7

Kwok, Hin. "Characterization of Epstein-Barr Virus (EBV) strains in primary EBV infection." Click to view the E-thesis via HKUTO, 2007. http://sunzi.lib.hku.hk/hkuto/record/b40203293.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kwok, Hin, and 郭軒. "Characterization of Epstein-Barr Virus (EBV) strains in primary EBV infection." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2007. http://hub.hku.hk/bib/B40203293.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Schmaus, Susanne. "Das BPLF1-Gen des Epstein-Barr-Virus." [S.l.] : [s.n.], 2002. http://deposit.ddb.de/cgi-bin/dokserv?idn=965095282.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Patsos, Georgios. "Epstein-Barr virus latent membrane protein 2A." Thesis, University of Bristol, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.399923.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Epstein-Barr virus. Epstein-Barr virus"

1

Minarovits, Janos, and Hans Helmut Niller, eds. Epstein Barr Virus. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4939-6655-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Wilson, Joanna B., and Gerhard H. W. May. Epstein-Barr Virus Protocols. New Jersey: Humana Press, 2001. http://dx.doi.org/10.1385/1592592279.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Münz, Christian, ed. Epstein Barr Virus Volume 1. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22822-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Münz, Christian, ed. Epstein Barr Virus Volume 2. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22834-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

author, Rickinson Alan, and Johannessen Ingólfur author, eds. Cancer virus: The story of Epstein-Barr Virus. Oxford, United Kingdom: Oxford University Press, 2014.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Epstein-Barr virus: Latency and transformation. Wymondham, Norfolk, UK: Caister Academic Press, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

Morgan, Andrew J. Development of Epstein-Barr virus vaccines. New York: Springer-Verlag, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Henderson, Sheila Ann. Epstein-Barr virus and cell survival. Birmingham: University of Birmingham, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

Levine, P. H., D. V. Ablashi, G. R. Pearson, and S. D. Kottaridis, eds. Epstein-Barr Virus and Associated Diseases. Boston, MA: Springer US, 1985. http://dx.doi.org/10.1007/978-1-4613-2625-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Takada, Kenzo, ed. Epstein-Barr Virus and Human Cancer. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56515-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Epstein-Barr virus. Epstein-Barr virus"

1

Johnson, Susan K. "Epstein-Barr Virus." In Encyclopedia of Clinical Neuropsychology, 1326. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-57111-9_552.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

LaCaille, Lara, Anna Maria Patino-Fernandez, Jane Monaco, Ding Ding, C. Renn Upchurch Sweeney, Colin D. Butler, Colin L. Soskolne, et al. "Epstein-Barr Virus." In Encyclopedia of Behavioral Medicine, 705–6. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_184.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Manet, Evelyne. "Epstein-Barr Virus." In Encyclopedia of Cancer, 1300–1304. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_1978.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Coia, John, and Heather Cubie. "Epstein-Barr virus." In The Immunoassay Kit Directory, 713–56. Dordrecht: Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-009-0359-3_15.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Niederman, James C., and Alfred S. Evans. "Epstein-Barr Virus." In Viral Infections of Humans, 253–83. Boston, MA: Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-0036-4_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Agarwal, Aniruddha, Madhuri Akella, Maria Cristina Savastano, Marco Rispoli, Bruno Lumbroso, and Vishali Gupta. "Epstein Barr Virus." In The Uveitis Atlas, 1–4. New Delhi: Springer India, 2017. http://dx.doi.org/10.1007/978-81-322-2506-5_53-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Agarwal, Aniruddha, Madhuri Akella, Maria Cristina Savastano, Marco Rispoli, Bruno Lumbroso, and Vishali Gupta. "Epstein Barr Virus." In The Uveitis Atlas, 359–61. New Delhi: Springer India, 2019. http://dx.doi.org/10.1007/978-81-322-2410-5_53.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Evans, Alfred S., and James C. Niederman. "Epstein-Barr Virus." In Viral Infections of Humans, 265–92. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4615-8138-3_10.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

van Balen, J. A. M., A. A. Demeulemeester, M. Frölich, K. Mohrmann, L. M. Harms, W. C. H. van Helden, L. J. Mostert, and J. H. M. Souverijn. "Epstein-Barr virus." In Memoboek, 92–93. Houten: Bohn Stafleu van Loghum, 2012. http://dx.doi.org/10.1007/978-90-313-9129-5_46.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Fingeroth, Joyce. "Epstein-Barr Virus." In Clinical Virology, 523–47. Washington, DC, USA: ASM Press, 2016. http://dx.doi.org/10.1128/9781555819439.ch25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Epstein-Barr virus. Epstein-Barr virus"

1

Prockop, Susan E., Ekaterina Doubrovina, Karim Baroudy, Farid Boulad, Ramzi Khalaf, Esperanza B. Papadopoulos, Craig Sauter, et al. "Abstract CT107: Epstein-Barr virus-specific cytotoxic T lymphocytes for treatment of rituximab-refractory Epstein-Barr virus-associated lymphoproliferative disorder." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-ct107.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Pierson, Duane, Alan Barrett, and Raymond Stowe. "Space flight-induced reactivation of latent Epstein-Barr virus." In 2001 Conference and Exhibit on International Space Station Utilization. Reston, Virigina: American Institute of Aeronautics and Astronautics, 2001. http://dx.doi.org/10.2514/6.2001-4904.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Efthymiou, G., C. Liaskos, E. Marou, E. Dardiotis, V. Tsimourtou, T. Scheper, W. Meyer, D. P. Bogdanos, G. Hadjigeorgiou, and L. I. Sakkas. "AB0751 The epstein-barr virus infection in systemic sclerosis." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.6599.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Levenson, A. R., F. Obeidin, and W. A. Muller. "Acute Liver Failure Due to Disseminated Epstein-Barr Virus." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6611.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Jin, Rui, Xue-mei Ma, Peng-xiang Zhao, Juan Feng, Li-ning Guo, Ru-gang Zhong, Yi Zeng, et al. "Detection of Epstein-Barr Virus in Idiopathic Orbital Inflammatory Pseudotumor." In 2010 International Conference on Biomedical Engineering and Computer Science (ICBECS). IEEE, 2010. http://dx.doi.org/10.1109/icbecs.2010.5462436.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Rasim, K., S. Suttner, M. Vogelhuber, W. Herr, A. Gessner, B. Seelbach-Goebel, and E. Reuschel. "Epstein-Barr-Virus (EBV)-assoziiertes Burkitt-Lymphom in der Schwangerschaft." In Kongressabstracts zur Tagung 2020 der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (DGGG). © 2020. Thieme. All rights reserved., 2020. http://dx.doi.org/10.1055/s-0040-1718347.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Vien, L. P., R. M. Marron, M. Kumaran, A. Aneja, F. C. Cordova, and M. Weir. "Epstein-Barr Virus-Associated Smooth Muscle Tumor in Lung Transplantation." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a5816.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Sakamoto, N., H. Yura, D. Okuno, T. Miyamura, A. Hara, T. Kido, H. Ishimoto, Y. Ishimatsu, and H. Mukae. "The Role of Epstein-Barr Virus-Encoded microRNAs in Pulmonary Fibrosis." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a2238.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Abboud, A., and H. E. Latham. "Concomitant Autoimmune and Cholestatic Hepatitis Secondary to Epstein-Barr Virus Infection." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3550.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Lesser, DJ, EY Sohn, and IA Perez. "The Utility of Screening for Epstein-Barr Virus in Pediatric Bronchoalveolar Lavage." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4793.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Epstein-Barr virus. Epstein-Barr virus"

1

Chang, Wing C., and Kishor G. Bhatia. Epstein Barr Virus and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2005. http://dx.doi.org/10.21236/ada442940.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chan, Wing C. Epstein-Barr Virus and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2004. http://dx.doi.org/10.21236/ada430721.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chan, Wing C., Kishor G. Bhatia, and Guimei Zhou. Epstein-Barr Virus and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2002. http://dx.doi.org/10.21236/ada412816.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chan, Wing C. Epstein-Barr Virus and Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, September 2003. http://dx.doi.org/10.21236/ada421791.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sugden, Bill. Assessing the Association of Epstein-Barr Virus With Breast Carcinoma. Fort Belvoir, VA: Defense Technical Information Center, June 2002. http://dx.doi.org/10.21236/ada407441.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Zhang, Luwen. Epstein Barr Virus and Blood Brain Barrier in Multiple Sclerosis. Fort Belvoir, VA: Defense Technical Information Center, January 2014. http://dx.doi.org/10.21236/ada596844.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Zhang, Luwen. Epstein Barr Virus and Blood Brain Barrier in Multiple Sclerosis. Fort Belvoir, VA: Defense Technical Information Center, July 2013. http://dx.doi.org/10.21236/ada593294.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Longnecker, Richard M. Epstein-Barr Virus: A Role for a Tumorigenic Virus in the Etiology of Breast Cancer. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada400450.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Tosato, Giovanna. Studies of Epstein-Barr Virus Infection and Immunoregulation in Patients with Aids and Aids-Related Disorders. Fort Belvoir, VA: Defense Technical Information Center, May 1991. http://dx.doi.org/10.21236/ada238805.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tosato, Giovanna. Studies of Epstein-Barr Virus Infection and Immunoregulation in Patients with Aids and Aids-Related Disorders. Fort Belvoir, VA: Defense Technical Information Center, May 1989. http://dx.doi.org/10.21236/ada220662.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!